The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes
Abstract Background Clinical and basic investigations have indicated a significant association between circulating growth differentiation factor 15 (GDF15) and cardiovascular disease; however, the relationship between GDF15 and lower extremity atherosclerotic disease (LEAD) has been less studied. Th...
Main Authors: | Xingxing He, Jiaorong Su, Xiaojing Ma, Wei Lu, Wei Zhu, Yufei Wang, Yuqian Bao, Jian Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-03-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12933-020-01020-9 |
Similar Items
-
Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus
by: Xingxing He, et al.
Published: (2017-06-01) -
Visit-to-visit variability of glycated albumin was associated with incidence or progression of lower extremity atherosclerotic disease
by: Yun Shen, et al.
Published: (2020-12-01) -
Association of Advanced Glycation End Products With Lower-Extremity Atherosclerotic Disease in Type 2 Diabetes Mellitus
by: Lingwen Ying, et al.
Published: (2021-09-01) -
Forty‐eight weeks of statin therapy for type 2 diabetes mellitus patients with lower extremity atherosclerotic disease: Comparison of the effects of pitavastatin and atorvastatin on lower femoral total plaque areas
by: Xieda Zhou, et al.
Published: (2021-07-01) -
Intima–media complex thickness and carotid atherosclerotic plaque formation in Lublin’s population in the context of selected comorbidities
by: Tomasz Słomka, et al.
Published: (2018-06-01)